Price alert —
Sign in to get a one-time email the moment TEM crosses your price. Free accounts included.
Sign in / create a free accountPrice chart
Loading…
Latest bar · TEM
Momentum reads · latest daily barGreen means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.
Financial overlay · last 12 quarters
The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.
| Quarter | Revenue | Net income | Op income | FCF | Net margin | Op margin |
|---|---|---|---|---|---|---|
| 2026-03-31 | $0.3B | $-0.1B | $-0.1B | $-0.1B | -36.2% | -24.3% |
| 2025-12-31 | $0.4B | $-0.1B | $-0.1B | $-0.0B | -14.8% | -16.7% |
| 2025-09-30 | $0.3B | $-0.1B | $-0.1B | $-0.1B | -23.9% | -18.3% |
| 2025-06-30 | $0.3B | $-0.0B | $-0.1B | $0.0B | -13.6% | -19.6% |
| 2025-03-31 | $0.3B | $-0.1B | $-0.1B | $-0.1B | -26.6% | -26.9% |
| 2024-12-31 | $nanB | $nanB | $nanB | $nanB | nan% | nan% |
Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.
Compare TEM vs peers
Line TEM up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.
Add tickers to compare with TEM
~30 metrics across Snapshot, OdysseyHQ zone, Valuation, Growth, Quality, Technicals, Sentiment, and Risk — with a weighted score and a one-line read on each.
Earnings replay · last 8 reports
How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.
| Date | EPS actual | EPS est | Surprise | Next-day |
|---|---|---|---|---|
| 2026-05-05 | -0.13 | -0.20 | +35.4% | -1.1% |
| 2026-02-24 | -0.04 | -0.05 | +22.1% | -7.3% |
| 2025-11-04 | -0.11 | -0.18 | +37.3% | -2.6% |
| 2025-08-08 | -0.22 | -0.25 | +13.0% | -0.1% |
| 2025-05-06 | -0.24 | -0.27 | +10.2% | +12.6% |
| 2025-02-24 | -0.18 | -0.15 | -17.5% | -15.1% |
| 2024-11-04 | -0.25 | -0.28 | +10.9% | -10.1% |
| 2024-08-06 | -0.63 | -1.79 | +64.8% | -4.5% |
Earnings markers are overlaid on the daily price chart above. Click a ▲ marker for that day's move.
Peer comparison · Healthcare
Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.
| Ticker ⇅ | Mkt cap ⇅ | P/E ⇅ | Fwd P/E ⇅ | P/S ⇅ | EV/EBITDA ⇅ | P/B ⇅ | Gross M ⇅ | Rev gr ⇅ | EPS gr ⇅ | FCF yld ⇅ |
|---|---|---|---|---|---|---|---|---|---|---|
| TEM ★ | $9B | — | -662.8 | 6.9 | -54.5 | 22.6 | 63.4% | 36.1% | — | -0.59% |
| LLY | $1,051B | 41.8 | 26.3 | 14.6 | 30.1 | 33.8 | 82.8% | 55.5% | 169.9% | 0.87% |
| UNH | $387B | 32.1 | 19.2 | 0.9 | 17.7 | 4.0 | 19.5% | 0.4% | 61.5% | 5.88% |
| JNJ | $609B | 29.3 | 19.7 | 6.2 | 18.4 | 7.5 | 68.1% | 6.6% | -1.0% | — |
| MRK | $315B | 36.0 | 13.2 | 4.8 | 12.1 | 6.9 | 76.7% | 4.9% | — | 4.46% |
| ABBV | $450B | 124.8 | 15.6 | 7.2 | 17.2 | -67.6 | 72.0% | 12.4% | -46.2% | 4.63% |
| PFE | $143B | 19.1 | 8.8 | 2.3 | 7.6 | 1.6 | 74.8% | 5.4% | -10.1% | 8.67% |
| TMO | $198B | 29.2 | 19.5 | 4.4 | 21.1 | 3.8 | 40.9% | 6.2% | 11.3% | 2.79% |
Auto-seeded from sector. Click any ticker to switch.
Ownership
Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.
Top institutional holders
Top-10 concentration: 33.85%
| Holder | Shares | % out |
|---|---|---|
| ARK Investment Management, LLC | 9,607,745 | 5.51% |
| Blackrock Inc. | 8,968,330 | 5.14% |
| BAILLIE GIFFORD & CO | 8,649,356 | 4.96% |
| Softbank Group Corporation | 5,405,406 | 3.10% |
| JPMORGAN CHASE & CO | 4,933,193 | 2.83% |
| Vanguard Capital Management LLC | 4,918,122 | 2.82% |
| Vanguard Portfolio Management LLC | 4,679,057 | 2.68% |
| Sumitomo Mitsui Trust Group, Inc. | 4,326,313 | 2.48% |
| Amova Asset Management Americas Inc | 4,326,313 | 2.48% |
| UBS Group AG | 3,234,387 | 1.85% |
Insider activity · 90d
0 buys / 15 sells · ratio 0.0 · Finnhub
- Fukushima Ryan SELL 167,763 @ $59.47
- Fukushima Ryan SELL 169,900 @ $58.55
- Fukushima Ryan SELL 173,377 @ $57.37
- Fukushima Ryan SELL 187,063 @ $56.80
- Fukushima Ryan SELL 201,047 @ $60.00
- LEFKOFSKY ERIC P SELL 15,390,469 @ $59.23
- LEFKOFSKY ERIC P SELL 15,426,989 @ $58.30
- LEFKOFSKY ERIC P SELL 15,435,309 @ $57.13
- LEFKOFSKY ERIC P SELL 15,476,487 @ $56.51
- LEFKOFSKY ERIC P SELL 15,514,198 @ $55.38
Analyst estimates
FinnhubWhat Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.
SEC filings
The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.
| Form | Filed | Description | Action |
|---|---|---|---|
| 4 | 2026-07-10 | Insider transaction (Form 4) | view · |
| 4 | 2026-07-08 | Insider transaction (Form 4) | view · |
| 4 | 2026-07-01 | Insider transaction (Form 4) | view · |
| 4 | 2026-06-29 | Insider transaction (Form 4) | view · |
| 4 | 2026-06-29 | Insider transaction (Form 4) | view · |
| 4 | 2026-06-03 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-29 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-26 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-26 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-26 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-26 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-26 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-26 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-26 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-26 | Insider transaction (Form 4) | view · |
| 8-K | 2026-05-22 | 8-K | view · |
| 4 | 2026-05-21 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-21 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-21 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-21 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-21 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-21 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-15 | Insider transaction (Form 4) | view · |
| 8-K | 2026-05-13 | 8-K | view · |
| 4 | 2026-05-06 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-06 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-06 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-06 | Insider transaction (Form 4) | view · |
| 4 | 2026-05-06 | Insider transaction (Form 4) | view · |
| 10-Q | 2026-05-05 | 10-Q | view · |
| 8-K | 2026-05-05 | 8-K | view · |
| 4 | 2026-04-30 | Insider transaction (Form 4) | view · |
| DEF 14A | 2026-04-07 | DEF 14A | view · |
| 4 | 2026-03-27 | Insider transaction (Form 4) | view · |
| 4 | 2026-03-04 | Insider transaction (Form 4) | view · |
| 4 | 2026-03-04 | Insider transaction (Form 4) | view · |
| 10-K | 2026-02-24 | 10-K | view · |
| 8-K | 2026-02-24 | 8-K | view · |
| 4 | 2026-02-20 | Insider transaction (Form 4) | view · |
| 4 | 2026-02-20 | Insider transaction (Form 4) | view · |
| 4 | 2026-02-20 | Insider transaction (Form 4) | view · |
| 4 | 2026-02-20 | Insider transaction (Form 4) | view · |
| 4 | 2026-02-20 | Insider transaction (Form 4) | view · |
| 4 | 2026-02-20 | Insider transaction (Form 4) | view · |
| 4 | 2026-02-13 | 4 | view · |
| 4 | 2026-02-04 | Insider transaction (Form 4) | view · |
| 4 | 2026-01-30 | Insider transaction (Form 4) | view · |
| 8-K | 2026-01-12 | 8-K | view · |
| 4 | 2026-01-07 | Insider transaction (Form 4) | view · |
| 4 | 2026-01-06 | Insider transaction (Form 4) | view · |
| 4 | 2025-12-22 | Insider transaction (Form 4) | view · |
| 4 | 2025-12-18 | Insider transaction (Form 4) | view · |
| 4 | 2025-12-12 | Insider transaction (Form 4) | view · |
| 4 | 2025-12-09 | Insider transaction (Form 4) | view · |
| 4 | 2025-12-03 | Insider transaction (Form 4) | view · |
| 4 | 2025-12-03 | Insider transaction (Form 4) | view · |
| 4 | 2025-12-03 | Insider transaction (Form 4) | view · |
| 4 | 2025-11-28 | Insider transaction (Form 4) | view · |
| 4 | 2025-11-25 | Insider transaction (Form 4) | view · |
| 4 | 2025-11-25 | Insider transaction (Form 4) | view · |
About TEM
Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests. The company also provides Lens, a software application for life sciences and advanced precision research; diagnostics services, such as NGS diagnostics, PCR profiling, and other anatomic and molecular pathology tests; and large-panel solid tumor and hematologic testing through multiple assays, with its core clinical assay (xT and xR) offering large panel DNA, RNA full transcriptome, and incidental germline findings through normal blood or saliva analyses. In addition, it provides genetic tests focused on inherited conditions; an nP assay for pharmacogenomic testing for patients with psychiatric conditions, including depression, general anxiety disorder, bipolar disorder, and other relevant diagnoses; Insigh…
Options picks · TEM
ITM + OTM ideas from the latest scanLoading…
Congress trades · TEM
STOCK Act disclosuresLoading…
SEC filings & insiders · TEM
EDGAR · liveLoading…
Holders · TEM
Institutions & insider activityLoading…